Xgeva and Myelodysplastic syndrome transformation - from FDA reports


There is no Myelodysplastic syndrome transformation reported by people who take Xgeva yet. This review analyzes which people have Myelodysplastic syndrome transformation with Xgeva. It is created by eHealthMe based on reports from FDA, and is updated regularly.



{pitch.title}



On Jun, 17, 2018

No report is found.

What's next:

Do you take Xgeva and have Myelodysplastic syndrome transformation?



Related studies

Xgeva

Xgeva has active ingredients of denosumab. It is often used in breast cancer. (latest outcomes from Xgeva 14,194 users)

Myelodysplastic Syndrome Transformation

Myelodysplastic syndrome transformation (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged and gets changed into rapid progressing cancer) has been reported by people with myelodysplastic syndrome, preventive health care, iron overload, multiple myeloma, idiopathic thrombocytopenic purpura (latest reports from 634 Myelodysplastic syndrome transformation patients).


Drugs that are associated with Myelodysplastic syndrome transformation
Myelodysplastic syndrome transformation
Could your condition cause Myelodysplastic syndrome transformation
Myelodysplastic syndrome transformation
Xgeva side effects
Browse all side effects of Xgeva
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Xgeva and have Myelodysplastic syndrome transformation


You are not alone. Join our personalized support groups:


Recent updates

General studies
Active Support Groups
Recent Predictions
Personalized studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.